BUY QUALITY PEPTIDES CANADA

LL-37

CA$90.00

Discover the precision and reliability of the Supreme Peptides LL-37 Peptide Vial, expertly formulated for advanced research applications. Each sterile vial is clearly labeled “LL-37” and contains a premium synthetic antimicrobial peptide with purity exceeding 99%, ensuring consistency and reproducibility for laboratory professionals. Intended strictly for research use only, this high-grade peptide is designed for investigative studies focused on innate immune signaling, antimicrobial activity, and inflammatory response pathways. Packaged in a clear glass vial, it offers optimal stability, accuracy, and ease of handling in controlled research protocols.

LL-37 is a naturally occurring human antimicrobial peptide derived from the cathelicidin family. It is widely studied in research settings for its broad-spectrum antimicrobial properties and its role in modulating immune responses, inflammation, and tissue repair signaling.


Product overview

LL-37 is a research-grade peptide composed of a 37-amino-acid sequence, derived from the human cathelicidin antimicrobial peptide hCAP-18. Preclinical research associates LL-37 with direct antimicrobial activity against bacteria, viruses, and fungi, as well as regulatory effects on immune cell signaling and inflammatory modulation. Its dual role in host defense and immune regulation makes it a valuable tool in immunology and infection-related research.


Key research features

Antimicrobial activity research:
LL-37 is widely investigated for its broad-spectrum antimicrobial effects, including disruption of microbial membranes and inhibition of pathogen growth in experimental models.

Immune modulation and inflammatory pathways:
Studies suggest LL-37 plays a role in regulating cytokine release and immune cell activation, making it relevant for research into inflammation and innate immunity.

Tissue repair and barrier function:
Research indicates LL-37 may contribute to wound healing processes and epithelial barrier protection, supporting studies in regenerative and immune defense biology.

LL-37 – Suggested Use (Research Context)
Typical Dose: 100–300 mcg per day
Route: Subcutaneous injection
Frequency: Once daily
Duration: As directed by a qualified professional

Disclaimer:
This product is intended for research purposes only.
Not for human or animal consumption.
No medical claims are made.
Keep out of reach of children.